Gene · 1759
DNM1: dynamin 1
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. DNM1: dynamin 1. Genes, record 1759. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1759
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q05193 | Dynamin-1 | 864 | 22 | Ensembl, GeneID, HGNC |
Source UniProt
Patents24
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 44405 | Q05193 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 9438 | Q05193 | Espacenet |
| JP 2025532779 A | 2025-10-03 | 1 | Q05193 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 9438 | Q05193 | Espacenet |
| WO 2024058196 A | 2024-03-21 | 1 | Q05193 | Espacenet |
| JP 2023551068 A | 2023-12-06 | 231 | Q05193 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 25936 | Q05193 | Espacenet |
| US 11371991 B2 | 2022-06-28 | 19 | Q05193 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 128907 | Q05193 | Espacenet |
| US 10725035 B2 | 2020-07-28 | 19 | Q05193 | Espacenet |
1 to 10 of 24
See all 24 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,568
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | DNM1 papers | Newest fiscal year |
|---|---|---|---|
| P30DA018343 | Yale/NIDA Neuroproteomics Center | 11 | 2025 |
| ZIADK060100 | Structure And Function Of Dynamin, A 100kd GTPase Involved In Endocytosis | 11 | 2025 |
| ZIANS003123 | Role of mitochondria in neurodegenerative diseases | 8 | 2025 |
| P30DK045735 | Yale Diabetes Research Center | 6 | 2025 |
| R01AA012404 | Gene Expression in the Human Alcoholic Brain | 6 | 2025 |
| R28AA012725 | Brain Tissue Resource Center for Alcohol Research | 5 | 2025 |
| R01MH101221 | Rare Mutations and Autism Spectrum Disorders | 4 | 2025 |
| R01NS031348 | Genetic Determinants of Epilepsy in Murine Systems | 4 | 2025 |
| R01NS102722 | Endosomal Platforms for Signaling Pain | 4 | 2025 |
| U01AA020926 | 2/11 Spatially Resolved, Single Cell, Neuroimmune Transcriptomes in Alcohol Dependence | 4 | 2025 |
1 to 10 of 1,568Source NIH's project files
See all 1,568 nih grantsPapers1,884
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Patient-Derived Organoids as a Model to Understand Tumor Microenvironment-Driven Nano-Bio Interactions - A Framework Towards Improved Nanomedicine Translation. | bioRxiv | 2026 | 42818659 | PubTator, text mining | PubMed |
| Ambrisentan rescues doxorubicin-induced cardiac apoptosis and mitochondrial bioenergetic dysfunction: Mechanistic insights into p53 and mTOR signaling. | Biochem Pharmacol | 2026 | 42727655 | PubTator, text mining | PubMed |
| High-fat diet-responsive DNM1 promotes hepatocellular carcinoma progression and predicts poor prognosis in viral-associated patients. | Am J Cancer Res | 2026 | 42724488 | PubTator, text mining | PubMed |
| Female chronic social defeat stress (femCSDS) maps synaptic, bioenergetic and metabolic proteome remodeling in the nucleus accumbens (NAc). | Front Syst Biol | 2026 | 42614171 | PubTator, text mining | PubMed |
| Large-scale whole-genome sequencing reveals the landscape and health implications of de novo mutations. | Nat Med | 2026 | 42567929 | PubTator, text mining | PubMed |
| Inhibition of ETS1/DRP1 axis attenuates intervertebral disc degeneration by suppressing excessive mitochondrial fission. | Cell Signal | 2026 | 42526698 | PubTator, text mining | PubMed |
| Targeting Synaptic Vesicle Endocytosis in Nociceptors Provides Sustained Pain Relief. | bioRxiv | 2026 | 42395445 | PubTator, text mining | PubMed |
| Refining Domain-Based Prognostication in DNM1 Encephalopathy: A Mild Phenotype Associated With a GTPase Domain Variant. | Am J Med Genet A | 2026 | 42286426 | PubTator, text mining | PubMed |
| Dapagliflozin Protects Cardiomyocytes against Doxorubicin-Induced Toxicity by Modulating Sirtuin 1/Sirtuin 3 and Ferroptosis Pathway. | ACS Pharmacol Transl Sci | 2026 | 42130718 | PubTator, text mining | PubMed |
| Modeling Synaptic Maturation From Growth Cone to Synapse in Human Organoids. | J Neurochem | 2026 | 42108706 | PubTator, text mining | PubMed |
1 to 10 of 1,884
See all 1,884 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1759
GET https://conductscience.org/api/genes/v1/1759/patents?page=2